1 – 104 of 104
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Overlaps and divergences between tauopathies and synucleinopathies : a duet of neurodegeneration
(
- Contribution to journal › Scientific review
-
Mark
AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease
(
- Contribution to journal › Article
- 2023
-
Mark
The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates
(
- Contribution to journal › Article
-
Mark
α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression
(
- Contribution to journal › Article
- 2022
-
Mark
Monitoring the interactions between alpha-synuclein and Tau in vitro and in vivo using bimolecular fluorescence complementation
(
- Contribution to journal › Article
-
Mark
Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
(
- Contribution to journal › Article
-
Mark
Brain region-specific microglial and astrocytic activation in response to systemic lipopolysaccharides exposure
(
- Contribution to journal › Article
-
Mark
Cryptococcal Hsf3 controls intramitochondrial ROS homeostasis by regulating the respiratory process
(
- Contribution to journal › Article
-
Mark
Aβ/Amyloid Precursor Protein-Induced Hyperexcitability and Dysregulation of Homeostatic Synaptic Plasticity in Neuron Models of Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner
(
- Contribution to journal › Article
-
Mark
Ferroptosis in Parkinson's disease : glia–neuron crosstalk
(
- Contribution to journal › Scientific review
-
Mark
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
(
- Contribution to journal › Article
-
Mark
Association between Parkinson’s Disease and Diabetes Mellitus : From Epidemiology, Pathophysiology and Prevention to Treatment
(
- Contribution to journal › Article
-
Mark
Aβ/APP-induced hyperexcitability and dysregulation of homeostatic synaptic plasticity in models of Alzheimer’s disease
2022)(
- Working paper/Preprint › Preprint in preprint archive
- 2021
-
Mark
Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
(
- Contribution to journal › Article
-
Mark
Coordinated bi-directional trafficking of synaptic vesicle and active zone proteins in peripheral nerves
(
- Contribution to journal › Article
-
Mark
Human α-synuclein overexpression in a mouse model of Parkinson’s disease leads to vascular pathology, blood brain barrier leakage and pericyte activation
(
- Contribution to journal › Article
-
Mark
Postmortem Studies of Fetal Grafts in Parkinson’s Disease : What Lessons Have We Learned?
(
- Contribution to journal › Scientific review
-
Mark
Inhibition of copper transporter 1 prevents α-synuclein pathology and alleviates nigrostriatal degeneration in AAV-based mouse model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation
(
- Contribution to journal › Article
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
(
- Contribution to journal › Article
-
Mark
Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis
(
- Contribution to journal › Article
-
Mark
The bacterial amyloids phenol soluble modulins from staphylococcus aureus catalyze alpha-synuclein aggregation
(
- Contribution to journal › Article
-
Mark
Impaired meningeal lymphatic drainage in patients with idiopathic Parkinson’s disease
(
- Contribution to journal › Article
- 2020
-
Mark
Autonomic ganglionic injection of α-synuclein fibrils as a model of pure autonomic failure α-synucleinopathy
(
- Contribution to journal › Article
-
Mark
Cynomolgus Monkeys With Spontaneous Type-2-Diabetes-Mellitus-Like Pathology Develop Alpha-Synuclein Alterations Reminiscent of Prodromal Parkinson’s Disease and Related Diseases
(
- Contribution to journal › Article
-
Mark
No symphony without bassoon and piccolo : Changes in synaptic active zone proteins in Huntington's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies
(
- Contribution to journal › Article
-
Mark
Exosomes in Parkinson's Disease : Current Perspectives and Future Challenges
(
- Contribution to journal › Article
-
Mark
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
(
- Contribution to journal › Article
-
Mark
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
(
- Contribution to journal › Article
-
Mark
Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
(
- Contribution to journal › Scientific review
-
Mark
Microbiome changes : an indicator of Parkinson's disease?
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Brain pericyte activation occurs early in Huntington's disease
(
- Contribution to journal › Article
-
Mark
2D polarization imaging as a low-cost fluorescence method to detect α-synuclein aggregation ex vivo in models of Parkinson’s disease
(
- Contribution to journal › Article
-
Mark
Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2017
-
Mark
Age-Dependent Alpha-Synuclein Accumulation and Phosphorylation in the Enteric Nervous System in a Transgenic Mouse Model of Parkinson’s Disease
(
- Contribution to journal › Article
-
Mark
Derivation of mouse embryonic stem cell lines from tyrosine hydroxylase reporter mice crossed with a human SNCA transgenic mouse model of Parkinson's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Extensive graft-derived dopaminergic innervation is maintained 24 years after transplantation in the degenerating parkinsonian brain.
2016) In Proceedings of the National Academy of Sciences of the United States of America 113(23). p.6544-6549(
- Contribution to journal › Article
- 2015
-
Mark
The Origin, Development and Molecular Diversity of Rodent Olfactory Bulb Glutamatergic Neurons Distinguished by Expression of Transcription Factor NeuroD1.
(
- Contribution to journal › Article
-
Mark
Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy.
(
- Contribution to journal › Article
-
Mark
Altered Sensory Experience Exacerbates Stable Dendritic Spine and Synapse Loss in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Human induced pluripotent stem cells in Parkinson's disease: A novel cell source of cell therapy and disease modeling.
(
- Contribution to journal › Scientific review
-
Mark
By activating matrix metalloproteinase-7, shear stress promotes chondrosarcoma cell motility, invasion and lung colonization.
(
- Contribution to journal › Article
-
Mark
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
(
- Contribution to journal › Article
- 2014
-
Mark
Reciprocal functions of Cryptococcus neoformans copper homeostasis machinery during pulmonary infection and meningoencephalitis.
(
- Contribution to journal › Article
-
Mark
Novel AAV-Based Rat Model of Forebrain Synucleinopathy Shows Extensive Pathologies and Progressive Loss of Cholinergic Interneurons.
(
- Contribution to journal › Article
-
Mark
Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro.
(
- Contribution to journal › Article
-
Mark
Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats.
(
- Contribution to journal › Article
- 2013
-
Mark
Dendritic Spine Instability Leads to Progressive Neocortical Spine Loss in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
Axonopathy in Huntington's disease.
(
- Contribution to journal › Scientific review
-
Mark
Active zone protein expression changes at the key stages of cerebellar cortex neurogenesis in the rat
(
- Contribution to journal › Article
-
Mark
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP.
(
- Contribution to journal › Article
-
Mark
NGF rescues hippocampal cholinergic neuronal markers, restores neurogenesis, and improves the spatial working memory in a mouse model of Huntington's Disease
(
- Contribution to journal › Article
- 2012
-
Mark
Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Neuronal Properties, In Vivo Effects, and Pathology of a Huntington's Disease Patient-Derived Induced Pluripotent Stem Cells
(
- Contribution to journal › Article
-
Mark
Late onset vascular dysfunction in the R6/1 model of Huntington's disease.
2012) In European Journal of Pharmacology(
- Contribution to journal › Article
- 2011
-
Mark
Identification of molecules derived from human fibroblast feeder cells that support the proliferation of human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
(
- Contribution to journal › Article
-
Mark
Neurogenesis In The R6/2 Mouse Model Of Huntington'S Disease Is Impaired At The Level Of Neurod1
(
- Contribution to journal › Article
-
Mark
Signs of Degeneration in 12-22-Year Old Grafts of Mesencephalic Dopamine Neurons in Patients with Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease.
(
- Contribution to journal › Article
- 2010
-
Mark
Foxa2 and Nurr1 Synergistically Yield A9 Nigral Dopamine Neurons Exhibiting Improved Differentiation, Function, and Cell Survival
(
- Contribution to journal › Article
-
Mark
Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease.
(
- Contribution to journal › Article
-
Mark
Characterization of Lewy Body Pathology in 12-and 16-Year Old Intrastriatal Mesencephalic Grafts Surviving in a Patient with Parkinson's Disease
(
- Contribution to journal › Published meeting abstract
-
Mark
GABAergic Differentiation Induced by Mash1 Is Compromised by the bHLH Proteins Neurogenin2, NeuroD1, and NeuroD2.
(
- Contribution to journal › Article
-
Mark
A simple method for large-scale generation of dopamine neurons from human embryonic stem cells.
(
- Contribution to journal › Article
-
Mark
Are synucleinopathies prion-like disorders?
(
- Contribution to journal › Article
- 2009
-
Mark
Mutant huntingtin interacts with {beta}-tubulin and disrupts vesicular transport and insulin secretion.
(
- Contribution to journal › Article
-
Mark
Divalent metal transporter 1 is involved in amyloid precursor protein processing and A{beta} generation.
(
- Contribution to journal › Article
-
Mark
Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment
(
- Contribution to journal › Article
-
Mark
Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis.
(
- Contribution to journal › Article
-
Mark
Neurogenin2 directs granule neuroblast production and amplification while NeuroD1 specifies neuronal fate during hippocampal neurogenesis.
(
- Contribution to journal › Article
- 2008
-
Mark
Effects on differentiation of embryonic ventral midbrain progenitors by Lmx1a, MSX1, Ngn2, and Pitx3.
2008) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 28(14). p.3644-3656(
- Contribution to journal › Article
-
Mark
Growth factors and feeder cells promote differentiation of human embryonic stem cells into dopaminergic neurons: a novel role for fibroblast growth factor-20.
(
- Contribution to journal › Article
-
Mark
Research in motion: the enigma of Parkinson's disease pathology spread.
(
- Contribution to journal › Scientific review
-
Mark
Critical issues of clinical human embryonic stem cell therapy for brain repair.
(
- Contribution to journal › Article
-
Mark
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation.
(
- Contribution to journal › Article
-
Mark
From bench to bed: the potential of stem cells for the treatment of Parkinson's disease
(
- Contribution to journal › Scientific review
- 2007
-
Mark
Restorative cell therapy for Parkinson's disease: A quest for the perfect cell
(
- Contribution to journal › Scientific review
-
Mark
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells.
(
- Contribution to journal › Article
-
Mark
Axonal transport of neuropeptides: Retrograde tracing study in live cell cultures of rat sympathetic cervical ganglia.
(
- Contribution to journal › Article
-
Mark
Adult neurogenesis in neurodegenerative diseases
2007) p.445-445(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Fibroblast growth factor-20 increases the yield of midbrain dopaminergic neurons derived from human embryonic stem cells.
(
- Contribution to journal › Article
- 2006
-
Mark
Cholinergic neuronal defect without cell loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Laminin {alpha}1 chain improves laminin {alpha}2 chain deficient peripheral neuropathy.
(
- Contribution to journal › Article
-
Mark
Neuropeptide Y-2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats
(
- Contribution to journal › Article
-
Mark
Failure of transdifferentiation of adult hematopoietic stem cells into neurons.
(
- Contribution to journal › Article
-
Mark
Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: Effect of in vitro differentiation on graft survival and teratoma formation
(
- Contribution to journal › Article
-
Mark
Transplantation in Parkinson's disease: The future looks bright.
(
- Contribution to journal › Article
- 2005
-
Mark
Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.
(
- Contribution to journal › Article
-
Mark
Stem cell-based therapy for Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Orexin loss in Huntington's disease.
(
- Contribution to journal › Article
-
Mark
The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient {beta}-cell mass and exocytosis.
(
- Contribution to journal › Article
-
Mark
The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.
(
- Contribution to journal › Article
-
Mark
Synaptic dysfunction in Huntington's disease: a new perspective
(
- Contribution to journal › Scientific review
-
Mark
Stromal cell-derived inducing activity does not promote dopaminergic differentiation, but enhances differentiation and proliferation of neural stem cell-derived astrocytes.
(
- Contribution to journal › Article
-
Mark
Depletion of rabphilin 3A in a transgenic mouse model (R6/1) of Huntington's disease, a possible culprit in synaptic dysfunction.
(
- Contribution to journal › Article
- 2004
-
Mark
Stem cell therapy for Parkinson's disease: where do we stand?
(
- Contribution to journal › Scientific review
- 2003
-
Mark
Grafting dopamine neurons in Parkinson's disease: do stem cells have a role in the future?
(
- Contribution to journal › Article
-
Mark
Huntington's disease: a synaptopathy?
(
- Contribution to journal › Article
- 2002
-
Mark
Stem cells: hype or hope?
(
- Contribution to journal › Scientific review